Literature DB >> 31300095

Acid Base Balance and Progression of Kidney Disease.

Wei Chen1, David S Levy2, Matthew K Abramowitz3.   

Abstract

A large body of work in animals and human beings supports the hypothesis that metabolic acidosis has a deleterious effect on the progression of kidney disease. Alkali therapy, whether pharmacologically or through dietary intervention, appears to slow CKD progression, but an appropriately powered randomized controlled trial with a low risk of bias is required to reach a more definitive conclusion. Recent work on urinary ammonium excretion has shown that the development of prognostic tools related to acidosis is not straightforward, and that application of urine markers such as ammonium may require more nuance than would be predicted based on our understanding of the pathophysiology.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Renal insufficiency; acidosis; alkali therapy; alkalosis; chronic; kidney disease progression

Mesh：

Substances：

Year:  2019        PMID： 31300095      PMCID： PMC6629436          DOI： 10.1016/j.semnephrol.2019.04.009

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN： 0270-9295            Impact factor:   5.299


  65 in total

1.  THE RENAL REGULATION OF ACID-BASE BALANCE IN MAN. II. FACTORS AFFECTING THE EXCRETION OF TITRATABLE ACID BY THE NORMAL HUMAN SUBJECT.

Authors:  W A Schiess; J L Ayer; W D Lotspeich; R F Pitts; P Miner
Journal:  J Clin Invest       Date:  1948-01       Impact factor: 14.808

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.

Authors:  Kalani L Raphael
Journal:  J Am Soc Nephrol       Date:  2017-10-13       Impact factor: 10.121

4.  Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.

Authors:  Avinash Kumar Dubey; Jayaprakash Sahoo; Balasubramanian Vairappan; Satish Haridasan; Sreejith Parameswaran; P S Priyamvada
Journal:  Nephrol Dial Transplant       Date:  2020-01-01       Impact factor: 5.992

Review 5.  Increased ammoniagenesis as a determinant of progressive renal injury.

Authors:  K A Nath; M K Hostetter; T H Hostetter
Journal:  Am J Kidney Dis       Date:  1991-06       Impact factor: 8.860

6.  Serum bicarbonate and long-term outcomes in CKD.

Authors:  Vandana Menon; Hocine Tighiouart; Nubia Smith Vaughn; Gerald J Beck; John W Kusek; Allan J Collins; Tom Greene; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2010-06-03       Impact factor: 8.860

7.  Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.

Authors:  Julia J Scialla; John Asplin; Mirela Dobre; Alex R Chang; James Lash; Chi-Yuan Hsu; Radhakrishna R Kallem; L Lee Hamm; Harold I Feldman; Jing Chen; Lawrence J Appel; Cheryl A M Anderson; Myles Wolf
Journal:  Kidney Int       Date:  2016-12-01       Impact factor: 10.612

8.  Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.

Authors:  L D Dworkin; T H Hostetter; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

Review 9.  TGF-beta in renal injury and disease.

Authors:  Erwin P Böttinger
Journal:  Semin Nephrol       Date:  2007-05       Impact factor: 5.299

10.  Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease.

Authors:  Kalani L Raphael; David J Carroll; Jennifer Murray; Tom Greene; Srinivasan Beddhu
Journal:  J Am Soc Nephrol       Date:  2017-04-06       Impact factor: 10.121
View more
  5 in total

1.  Evidence for disordered acid-base handling in calcium stone-forming patients.

Authors:  Elaine M Worcester; Kristin J Bergsland; Daniel L Gillen; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-02

2.  Metabolic Acidosis and CKD Progression.

Authors:  Nicolaos E Madias
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-07       Impact factor: 8.237

Review 3.  Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment.

Authors:  Hyo Jin Kim
Journal:  Electrolyte Blood Press       Date:  2021-12-23

4.  Low-grade metabolic acidosis as a driver of chronic disease: a 21st century public health crisis.

Authors:  James J DiNicolantonio; James O'Keefe
Journal:  Open Heart       Date:  2021-10

5.  Oral Acid Load Down-Regulates Fibroblast Growth Factor 23.

Authors:  Angela Vidal; Carmen Pineda; Ana I Raya; Rafael Rios; Azahara Espartero; Juan R Muñoz-Castañeda; Mariano Rodriguez; Escolastico Aguilera-Tejero; Ignacio Lopez
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.